In agreement with published studies, Onc-p53 NSCLC cells demonstrate higher basal levels of ROS (and lower GSH levels) compared with WT p53 NSCLC cells (Fig. 2; Supplementary Fig. S1D). Here, TP53 is linked to non-small cell lung carcinoma.